Potential and Current Use of N -Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of Aging

ISSN： 1170-229X

Source： Drugs & Aging, Vol.18, Iss.10, 2001-10, pp. : 717-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Methyl-D-Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 749-770

Bentham Science Publishers

Access to resources Recommend Favorite

The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-01 ,pp. : 16-25

Bentham Science Publishers

Access to resources Recommend Favorite

Cataleptic effects of γ-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA_B receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists

By Koek Wouter France Charles

Psychopharmacology, Vol. 199, Iss. 2, 2008-08 ,pp. : 191-198

Springer Publishing Company

Access to resources Recommend Favorite

The role of N-Methyl-D-Aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes

By Heresco-Levy U. Javitt D.C.

European Neuropsychopharmacology, Vol. 8, Iss. 2, 1998-05 ,pp. : 141-152

Elsevier

Access to resources Recommend Favorite

A novel NMDA receptor antagonist protects against N-methyl-d-aspartate- and glutamate-induced neurotoxicity in the goldfish retina

By Tyan S.-H. Sue T.-Y. Hon Y.-S. Gean P.-W. Chang Y.-C.

European Journal of Pharmacology, Vol. 321, Iss. 2, 1997-02 ,pp. : 171-179

Elsevier

Access to resources Recommend Favorite